Rankings
▼
Calendar
VCEL
Vericel Corporation
$2B
FY 2013 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$19,000
-9.5% YoY
Gross Profit
$15,000
78.9% margin
Operating Income
-$21M
-110336.8% margin
Net Income
-$16M
-82221.1% margin
EPS (Diluted)
$-5.18
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$926,000
Balance Sheet
Total Assets
$9M
Total Liabilities
$5M
Stockholders' Equity
$4M
Cash & Equivalents
$8M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$19,000
$21,000
-9.5%
Gross Profit
$15,000
$15,000
+0.0%
Operating Income
-$21M
-$34M
+37.9%
Net Income
-$16M
-$29M
+47.0%
← FY 2012
All Quarters
FY 2014 →
VCEL FY 2013 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena